TMPRSS2-ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer
Recommended Citation
Fisher KW, Zhang S, Wang M, Montironi R, Wang L, Baldrige LA, Wang JY, MacLennan GT, Williamson SR, Lopez-Beltran A, Cheng L. TMPRSS2-ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer. Mol Carcinog. 2017 Mar;56(3):814-820.
Document Type
Article
Publication Date
3-1-2017
Publication Title
Molecular carcinogenesis
Abstract
T1a prostate cancers (cancer found incidentally in transurethral resection,
Medical Subject Headings
Aged; Aged, 80 and over; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Neoplasm Staging; Oncogene Proteins, Fusion; PTEN Phosphohydrolase; Prostatic Neoplasms
PubMed ID
27500376
Volume
56
Issue
3
First Page
814
Last Page
820
COinS
